Strong HPV Vaccine Response Predicts Better Survival with Chemotherapy
Abstract
Patients with HPV16+ cervical cancer and high T-cell responses to an HPV16 vaccine survived longer.
Patients with HPV16+ cervical cancer and high T-cell responses to an HPV16 vaccine survived longer.